CANDRIAM S.C.A. – Eli Lilly and Company Transaction History
CANDRIAM S.C.A. portfolio value:
$177.51M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +14.20% | 68.25K shares | 21.66M | $323.35 | 548.96K |
Q2 2022 | share | Decrease | -18.59% | -109.75K shares | -13.23M | $324.23 | 480.70K |
Q1 2022 | share | Increase | +13.08% | 68.27K shares | 24.84M | $286.37 | 590.46K |
Q4 2021 | share | Increase | +279.64% | 384.63K shares | 112.45M | $277.25 | 522.18K |
Q3 2021 | share | Increase | +12.94% | 15.75K shares | 3.82M | $230.3 | 137.54K |
Q2 2021 | share | Decrease | -39.33% | -78.94K shares | -4.60M | $228.04 | 121.79K |
Q1 2021 | share | 0.00% | 0 shares | -1.33M | $184.81 | 200.73K | |
Q4 2020 | share | Decrease | -19.96% | -50.06K shares | -3.22M | $166.32 | 200.73K |
Q3 2020 | share | Decrease | -13.52% | -39.22K shares | -10.49M | $145.05 | 250.80K |
Q2 2020 | share | Decrease | -2.95% | -8.80K shares | 9.22M | $160.1 | 290.02K |
Q1 2020 | share | 0.00% | 0 shares | -882K | $134.64 | 298.82K | |
Q4 2019 | share | Increase | +10.55% | 28.52K shares | 9.04M | $126.91 | 298.82K |
Q3 2019 | share | Increase | +47.66% | 87.25K shares | 10.03M | $107.36 | 270.30K |
Q2 2019 | share | Increase | +1.13% | 2.05K shares | -3.29M | $105.74 | 183.05K |
Q1 2019 | share | Increase | +22.55% | 33.30K shares | 6.39M | $123.17 | 181.00K |
Q4 2018 | share | Decrease | -8.87% | -14.37K shares | -302K | $109.26 | 147.70K |
Q3 2018 | share | Decrease | -38.83% | -102.87K shares | -5.21M | $100.8 | 162.08K |
Q2 2018 | share | Decrease | -16.60% | -52.73K shares | -1.97M | $79.72 | 264.95K |
Q1 2018 | share | Decrease | -34.70% | -168.80K shares | -16.50M | $71.78 | 317.69K |
Q4 2017 | share | Increase | +13.03% | 56.06K shares | 4.27M | $77.79 | 486.49K |
Q3 2017 | share | Increase | +166.70% | 269.03K shares | 23.53M | $78.29 | 430.42K |
Q2 2017 | share | Increase | +3.01% | 4.72K shares | 105K | $74.85 | 161.38K |
Q1 2017 | share | Increase | +80.37% | 69.80K shares | 6.79M | $76 | 156.66K |
Q4 2016 | share | Decrease | -42.59% | -64.42K shares | -5.75M | $66.02 | 86.85K |
Q3 2016 | share | Decrease | -42.44% | -111.55K shares | -8.55M | $71.57 | 151.27K |
Q2 2016 | share | Increase | +54.50% | 92.71K shares | 8.51M | $69.79 | 262.83K |
Q1 2016 | share | Increase | +1.62% | 2.70K shares | -1.92M | $63.39 | 170.12K |